Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Status:
Completed
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effectiveness of fexinidazole administered to patients with g-HAT at
all stages of the disease. The aim of the present study is to provide additional information
on the effectiveness and safety of fexinidazole and to assess its use under conditions as
close as possible to those in real life, both in patients treated on an out-patient basis and
in the hospital setting, depending on clinical status